MICA and neoplasm: Dysregulating tumor glycolysis could render tumor cells sensitive to natural killer cell (NK cell)‐mediated immunotherapy by upregulating stress‐inducible NKG2DLs (MIC‐A/B) and affecting the acidity of tumor microenvironment (TME), which increases the penetrability or infiltration of the antitumor immune system.12